健康的饮食和生活方式
Search documents
一文看懂!服用司美格鲁肽时如何应对平台期(建议转发+收藏)
GLP1减重宝典· 2026-01-29 15:39
Core Viewpoint - The article discusses the challenges of weight loss, particularly the phenomenon of weight loss plateaus experienced by individuals using GLP-1 medications, emphasizing the importance of lifestyle changes and psychological support in overcoming these challenges [4][5][10]. Group 1: Understanding Weight Loss Plateaus - Weight loss plateaus are a common occurrence during weight loss interventions, including diet, surgery, and medications, and are a self-protective mechanism [4]. - Plateaus are not a matter of willpower but are closely related to brain chemistry and metabolism, where the brain releases hunger hormones and metabolism slows down, making it harder to burn calories [5]. Group 2: Lifestyle Changes and Support - Personalized support from registered dietitians and health coaches is more effective than trendy diets, as GLP-1 medications are approved by the FDA as adjuncts to behavioral modification [6]. - A healthy diet should focus on low-fat, low-sodium, and high-fiber foods while avoiding high-fat and high-sugar items. Regular moderate exercise (150 minutes per week) is shown to lead to greater fat loss and weight maintenance compared to medication alone [6]. Group 3: Medication Adherence - Patients are expected to reach a weight loss plateau, which does not indicate that GLP-1 medications like semaglutide and tirzepatide have stopped working; rather, the body's resistance has matched the intervention intensity [7]. - Continuing the use of GLP-1 medications is recommended even during plateaus, as they may still facilitate weight loss despite the apparent stagnation [7]. Group 4: Addressing Mental Health - There is a significant correlation between obesity and mental health issues, with obesity patients having a 55% increased risk of depression, and vice versa [8]. - Cognitive Behavioral Therapy (CBT) can help address harmful thought patterns and improve patients' sense of control and autonomy, making psychological support crucial for those undergoing GLP-1 treatment [8]. Group 5: Recognizing Obesity as a Chronic Disease - Obesity is recognized as a chronic disease, and it is not surprising that many face resistance to weight loss regardless of the intervention [9]. - Studies indicate that even a 5% to 10% reduction in weight can lead to significant health benefits, highlighting that weight loss is not the only measure of success [9].